NDC 80425-0228-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0228
- Requested NDC
- 80425-0228-01
- Package NDCs from labels
- 80425-0228-1, 80425-0228-2, 80425-0228-3, 80425-0228-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0228-1 | Ondansetron | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 6 | |
| 80425-0228-1 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 6 | |
| 80425-0228-2 | Ondansetron | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 6 | |
| 80425-0228-2 | Ondansetron | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 6 | |
| 80425-0228-3 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0228 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, 5 package rows | 20240224_f1a0b9ee-c1d2-7818-e053-2995a90a3e96.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0228-1 | EA - Each | 80425-0228 | fa25cf8c-1b2c-4fa0-a25f-e449a12dc055 | 1 | 2023-04-07 |
| 80425-0228-2 | EA - Each | 80425-0228 | be69a6f8-bffd-4c20-b029-ee37c66a28e3 | 1 | 2023-06-06 |
| 80425-0228-3 | EA - Each | 80425-0228 | d416152b-61d5-41ee-b10c-d0ebec5d3c51 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 40258e4b-5e67-46c0-8ef0-3e8bfe36ba11 | 2026-04-16 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 5bacb621-1261-25d9-e053-2991aa0afa3b | 2026-04-08 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| ONDANSETRON | ONDANSETRON | Direct Rx | b38feff2-900a-4e0c-8260-8f090edbc0bc | 2026-03-17 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | df736abd-9cec-4e90-e053-2995a90aab5e | 2026-03-13 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals, Inc. | 50383ef5-6e6e-63a7-e054-00144ff88e88 | 2026-03-04 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | ef6ce203-4ae3-19c9-e053-2995a90af796 | 2026-02-27 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 378d0963-d026-4478-8202-fbb636904a37 | 2026-02-18 | Warnings, Adverse reactions | ANDA090469 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 9dff6676-e69e-779d-e053-2995a90a7c81 | 2026-01-27 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 76666e7e-3312-6f9d-e053-2991aa0af705 | 2026-01-23 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | d117de5f-64e5-464c-b782-de0f07e66c8e | 2026-01-20 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 26aff90c-49ea-46ac-bbf3-c188c2b061c9 | 2026-01-14 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Glenmark Pharmaceuticals Inc., USA | eee5217a-eba8-463a-812d-bf3c66f0934f | 2026-01-08 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | f2b502e2-03ed-fe5c-e053-2995a90a368e | 2026-01-01 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | db9a0d22-9339-4319-e053-2a95a90a9592 | 2026-01-01 | Warnings, Adverse reactions | ANDA090469 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | e07c38c0-e1c2-01de-e053-2995a90a390a | 2026-01-01 | Warnings, Adverse reactions | ANDA090469 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | f29f5cfa-3cc4-7d53-e053-2995a90ae844 | 2025-12-26 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Ipca Laboratories Limited | 8e24f935-87fe-4b6a-b265-60b1039f38d5 | 2025-12-22 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | AvKARE | 352de988-d166-c2d8-e063-6294a90acc01 | 2025-11-17 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 7949c245-b79f-4eaf-a75f-9a17bd7bd307 | 2025-11-06 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Proficient Rx LP | 81366c85-c6c9-4a9a-9fe5-cdd8c2d19f74 | 2025-11-01 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.